Literature DB >> 999788

Immunization of mice against Coxsackievirus B3 and prevention of foetal growth retardation.

A B Lansdown, J D Brown.   

Abstract

Coxsackievirus B3 infection in pregnant mice leads to a severe pancreatitis with a retardation of foetal growth and increased wastage. The present study demonstrates that animals may be immunized actively or passively against this infection to allow foetal development to proceed normally. Active immunization was achieved by injecting a low dose of live virus into 4-week-old animals. These mice were then mated at 10 weeks and given a high dose of virus on the eighth day of pregnancy. Examination at 18 days' gestation revealed that foetal growth was not significantly different from the controls injected with heat-killed virus, and pathological changes in the mothers were not seen. Animals were passively immunized against Coxsackievirus B3 in pregnancy by injecting serum from immunized animals 1 day before the high dose of live virus was given. This procedure also protected against the effects of the virus and litter sizes and foetal weights were normal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 999788      PMCID: PMC2041221     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  11 in total

1.  Pathological changes in pregnant mice infected with Coxsackievirus B3 and given dietary casein hydrolysate supplement.

Authors:  A B Lansdown
Journal:  Br J Exp Pathol       Date:  1975-08

2.  Mitigation of virus-induced foetal growth retardation in mice by dietary casein hydrolysate.

Authors:  A B Lansdown; C R Coid; D B Ramsden
Journal:  Nature       Date:  1975-04-17       Impact factor: 49.962

3.  Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B; evidence of intrauterine infection with this agent.

Authors:  S KIBRICK; K BENIRSCHKE
Journal:  Pediatrics       Date:  1958-11       Impact factor: 7.124

4.  The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus.

Authors:  B Rager-Zisman; A C Allison
Journal:  J Gen Virol       Date:  1973-06       Impact factor: 3.891

5.  Histochemical demonstration of changes in liver cell enzymes in pregnant mice infected with Coxsackie B3 virus.

Authors:  A B Lansdorn; S J Ellaby
Journal:  Histochemistry       Date:  1974

6.  Effects of immunosuppression on coxsackie B-3 virus infection in mice, and passive protection by circulating antibody.

Authors:  B Rager-Zisman; A C Allison
Journal:  J Gen Virol       Date:  1973-06       Impact factor: 3.891

7.  Rubella reinfection in pregnancy followed by transmission to the fetus.

Authors:  T Eilard; O Strannegård
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

8.  Fetal mouse weights and albumin-alpha 1-fetoprotein ratios after maternal infection with Coxsackievirus B3.

Authors:  C R Coid; D B Ramsden; M J Healy
Journal:  Med Microbiol Immunol       Date:  1974-06-19       Impact factor: 3.402

9.  Pathological changes in pregnant mice infected with Coxsackie B3 virus as a possible cause of retarded foetal development.

Authors:  A B Lansdown; C R Coid
Journal:  Br J Exp Pathol       Date:  1974-04

10.  Retardation of foetal growth and plasma protein development in foetuses from mice injected with Coxsackie B3 virus.

Authors:  C R Coid; D B Ramsden
Journal:  Nature       Date:  1973-02-16       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.